29
Jan
As the public conflict between the European Commission and the British-Swedish pharma giant over apparent shortages in COVID-19 vaccine deliveries continues to heat up, the Commission has today implemented a new export transparency regime, allowing Member States to potentially block their exports.
In recent days, Commission considerations of whether to institute greater oversight of which, and crucially how much, Covid-19 vaccines, manufactured in the EU, have raised considerable fears across the globe of an EU “export ban.”
Under the new mechanism,...